Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Melanie A. Stowell, Tara Thomas-Gale, Hendrée E. Jones, Ingrid Binswanger & Deborah J. Rinehart. (2022) Perspectives among women receiving medications for opioid use disorder: Implications for development of a peer navigation intervention to improve access to family planning services. Substance Abuse 43:1, pages 722-732.
Read now
Read now
Miriam McQuade, Neha Reddy, Kyle Barbour & Lauren Owens. (2021) Integrating reproductive health care into substance use disorder services. International Review of Psychiatry 33:6, pages 572-578.
Read now
Read now
Heidi S. Melbostad, Gary J. Badger, Catalina N. Rey, Lauren K. MacAfee, Anne K. Dougherty, Stacey C. Sigmon & Sarah H. Heil. (2020) Contraceptive Knowledge among Females and Males Receiving Medication Treatment for Opioid Use Disorder Compared to Those Seeking Primary Care. Substance Use & Misuse 55:14, pages 2403-2408.
Read now
Read now
Lauren Owens, Elizabeth Micks, Courtney Moreno & Sara Glick. (2020) Reproductive Health Care Utilization by Women Who Inject Drugs and Exchange Sex in the Seattle Area. Substance Use & Misuse 55:12, pages 2020-2024.
Read now
Read now
Gretchen E. Ely, Braden K. Linn, Michele Staton, Travis W. Hales, Kafuli Agbemenu & Eugene Maguin. (2020) Contraceptive use in Appalachian women who use drugs and were recruited from rural jails. Social Work in Health Care 59:6, pages 365-386.
Read now
Read now
Articles from other publishers (20)
Eung-Mi Lee, Sarah K. O'Connor, Rushina Pancholi, Katharine O. White, Elisabeth Woodhams & Elizabeth W. Patton. (2023) “Meeting Patients Where They're at”: Clinician Perspectives on Integration of Family Planning Services into Office-Based Addiction Treatment. Journal of Addiction Medicine 17:6, pages 702-707.
Crossref
Crossref
Enora Le Roux, Aurélie Bourmaud, Paul Jacquin, Nizar Mahlaoui, Aurélien Guffroy, Alexandre Belot, Mélanie Romier, Jane Sattoe, AnneLoes Van Staa, Corinne Alberti, Hélène Mellerio & Agnès Dumas. (2023) Clinics dedicated to transition preparation for adolescents and young adults with chronic conditions: Factors influencing their use. Archives de Pédiatrie 30:8, pages 617-619.
Crossref
Crossref
Brooke S. West, Sugy Choi & Mishka Terplan. (2023) In our responses to the overdose epidemic, we cannot forget pregnant and postpartum people. International Journal of Drug Policy 120, pages 104153.
Crossref
Crossref
Anna L. Herriott. (2023) “I just want the best for him.” Pregnancy in the context of substance use disorders: Perspectives of postpartum women. Birth.
Crossref
Crossref
Melissa N. Slavin, Brooke S. West, Frances R. Levin & Nabila El-Bassel. (2023) Women with substance use disorders are highly impacted by the overturning of Roe v. Wade: Advocacy steps are urgently needed. Journal of Substance Use and Addiction Treatment 150, pages 209052.
Crossref
Crossref
Elizabeth Charron, Jacqueline Kent-Marvick, Tyler Gibson, Eliza Taylor, Kelsey Bouwman, Gelina M. Sani, Sara E. Simonsen, Rebecca H. Stone, Jennifer E. Kaiser & Mary M. McFarland. (2023) Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review. Preventive Medicine Reports 32, pages 102111.
Crossref
Crossref
Susan Tross, Anya Y. Spector, Melissa M. Ertl, Hayley Berg, Eva Turrigiano & Susie Hoffman. (2022) A Qualitative Study of Barriers and Facilitators of PrEP Uptake Among Women in Substance Use Treatment and Syringe Service Programs. AIDS and Behavior 27:4, pages 1162-1172.
Crossref
Crossref
Emily A. Hurley, Kathy Goggin, Kimberly Piña-Brugman, Janelle R. Noel-MacDonnell, Andrea Allen, Sarah Finocchario-Kessler & Melissa K. Miller. (2023) Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study. Harm Reduction Journal 20:1.
Crossref
Crossref
Tracy R. Nichols, Meredith R. Gringle, Amber Welborn & Amy Lee. (2022) “We Have to Keep Advocating and Helping and Doing What We Can”: Examining Perinatal Substance Use Services in the Absence of Integrated Treatment Programs. Journal of Drug Issues 53:1, pages 18-36.
Crossref
Crossref
Deborah J. Rinehart, Melanie Stowell, Kaeli Barrett, Katie Langland, Tara Thomas-Gale, Alia Al-Tayyib & Ryan O’Connell. (2023) Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development. Journal of Addiction Medicine 17:1, pages 21-27.
Crossref
Crossref
Madelyn McCartin, Lindsay M. Cannon, Roxanne F. Harfmann, Vanessa K. Dalton, Lauren K. MacAfee & Yasamin Kusunoki. (2022) Stigma and Reproductive Health Service Access Among Women in Treatment for Substance Use Disorder. Women's Health Issues 32:6, pages 595-601.
Crossref
Crossref
Danielle Shelton, Melinda Ramage, Phillip Hughes & Casey Tak. (2022) Factors associated with contraceptive use among postpartum women with substance use disorder. Sexual & Reproductive Healthcare 33, pages 100764.
Crossref
Crossref
Divyaa Balaji, Linwei He, Stefano Giani, Tibor Bosse, Reinout Wiers & Gert-Jan de Bruijn. (2022) Effectiveness and acceptability of conversational agents for sexual health promotion: a systematic review and meta-analysis. Sexual Health 19:5, pages 391-405.
Crossref
Crossref
Jonathan J. K. Stoltman, Laura R. Lander, Julie H. Patrick, Mishka Terplan & Hendrée E. Jones. (2022) Interest in Co-located Reproductive and Sexual Health Services Among Women and Men Receiving Medication for Opioid Use Disorder in an Outpatient Treatment Clinic. Frontiers in Psychiatry 13.
Crossref
Crossref
Elizabeth Charron, Farah Tahsin, Rwina Balto, Kacey Y. Eichelberger, Lori Dickes, Sara E. Simonsen & Rachel M. Mayo. (2022) Provider Perspectives of Barriers to Contraceptive Access and Use among Women with Substance Use Disorders. Women's Health Issues 32:2, pages 165-172.
Crossref
Crossref
Stephani L. Stancil, Melissa K. Miller, Alex Duello, Sarah Finocchario-Kessler, Kathy Goggin, Rachel P. Winograd & Emily A. Hurley. (2021) Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse. Harm Reduction Journal 18:1.
Crossref
Crossref
Orli K. Florsheim, Dallas Augustine, Megan M. Van Ligten, Heike Thiel de Bocanegra & Rachel Perry. (2021) Understanding Contraceptive Needs of Women Who Inject Drugs in Orange County: A Qualitative Study. Journal of Addiction Medicine 15:6, pages 498-503.
Crossref
Crossref
Sarah H. Heil, Heidi S. Melbostad, Alexis K. Matusiewicz, Catalina N. Rey, Gary J. Badger, Donald S. Shepard, Stacey C. Sigmon, Lauren K. MacAfee & Stephen T. Higgins. (2021) Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy. JAMA Psychiatry 78:10, pages 1071.
Crossref
Crossref
Deborah J. Rinehart, Melanie Stowell, Adriana Collings, M. Joshua Durfee, Tara Thomas-Gale, Hendrée E. Jones & Ingrid Binswanger. (2021) Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention. Journal of Substance Abuse Treatment 126, pages 108318.
Crossref
Crossref
Elizabeth Charron, Lior Rennert, Rachel M. Mayo, Kacey Y. Eichelberger, Lori Dickes & Khoa D. Truong. (2021) Contraceptive initiation after delivery among women with and without opioid use disorders: A retrospective cohort study in a statewide Medicaid population, 2005–2016. Drug and Alcohol Dependence 220, pages 108533.
Crossref
Crossref